The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•7 April 2026•

1 min read

John Dorfman Unveils Q1 'Casualty List' of Stocks Poised for Rebound

A man in a suit over a stock chart with 'Mondelez International' text, surrounded by chocolate, cocoa beans, factories, and shops.

Key Facts

1John Dorfman identified 5 stocks that were heavily sold off in Q1 and are poised for a rebound: Humana, Cognizant, Abercrombie & Fitch, Harmony Biosciences, and Thor Industries.

2The recommendations are based on low valuations and specific industry dynamics despite significant drops early in the year.

3Dorfman's previous year's list significantly outperformed the S&P 500 index.

Financial columnist John Dorfman has released his 'Casualty List' for the first quarter of 2026, highlighting five stocks that faced heavy sell-offs but are positioned for a significant recovery. The selected companies include Humana, Cognizant, Abercrombie & Fitch, Harmony Biosciences, and Thor Industries. Dorfman’s recommendations are rooted in low valuations and specific industry dynamics, suggesting these equities were unjustly penalized by the market early in the year. This value-investing approach identifies a significant gap between the intrinsic value of these firms and their current market prices. Notably, Dorfman’s previous annual list demonstrated a strong track record, significantly outperforming the S&P 500 index. While these picks represent individual recommendations, they highlight potential opportunities for retail investors seeking turnaround candidates in a volatile environment.